Publications by authors named "Pascale Frere"

Claim this Profile
R
Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
Gaëtan Vanstraelen, Frédéric Baron, Evelyne Willems, Christophe Bonnet, Kaoutar Hafraoui

Exp Hematol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation.
Gaëtan Vanstraelen, Pascale Frère, Marie-Christine Ngirabacu, Evelyne Willems, Georges Fillet

Exp Hematol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation.
Pascale Frère, Maguy Pereira, Georges Fillet, Yves Beguin

Eur J Haematol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation.
Gaëtan Vanstraelen, Frédéric Baron, Pascale Frère, Kaoutar Hafraoui, Georges Fillet

Haematologica· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.
Frédéric Baron, Nicole Schaaf-Lafontaine, Stéphanie Humblet-Baron, Nathalie Meuris, Emilie Castermans

Transplantation· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
Frédéric Baron, Pascale Frère, Georges Fillet, Yves Beguin

Clin Cancer Res· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion.
Frédéric Baron, Pascale Frère, Georges Fillet, Yves Beguin

Br J Haematol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update.
Frédéric Baron, Pascale Frère, Etienne Baudoux, Nicole Schaaf-Lafontaine, Georges Fillet

Haematologica· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood stem cell transplantation when started soon after engraftment.
Frédéric Baron, Pascale Frère, Yves Beguin

Haematologica· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma.
Frédéric Baron, Pascale Frère, Etienne Baudoux, Brieuc Sautois, Georges Fillet

Haematologica· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of nonmyeloablative stem cell transplantation and Imatinib in accelerated phase CML.
Frédéric Baron, Pascale Frère, Christian Herens, Georges Fillet, Yves Beguin

Haematologica· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells.
Frédéric Baron, Etienne Baudoux, Pascale Frère, Soraya Tourqui, Nicole Schaaf-Lafontaine

J Hematother Stem Cell Res· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis